Latest News

SBA Communications (NASDAQ:SBAC) reported third-quarter results that management said met expectations, supported by domestic leasing activity, high tower cash flow margins and capital returns to shareholders. The company also raised the midpoint of its 2026 outlook for adjusted funds from operations

Travere Therapeutics (NASDAQ:TVTX) reported third-quarter results marked by record FILSPARI sales, continued early adoption in focal segmental glomerulosclerosis (FSGS), and progress across its kidney-disease and rare-disease pipeline. Total U.S. net product sales reached $220.2 million in the thir

Sonic Automotive (NYSE:SAH) said its diversified automotive retail model, including franchised dealerships, EchoPark used-vehicle stores and powersports locations, positions the company to pursue growth while balancing exposure to different market conditions. Speaking at the 50th Annual Automotive

EverQuote (NASDAQ:EVER) reported record third-quarter results, with revenue rising 25% year over year to $218.1 million and Adjusted EBITDA increasing 41% to $35.5 million, as insurer demand remained broad-based and the company expanded its artificial intelligence-focused offerings. Chief Executive

Harmonic (NASDAQ:HLIT) reported third-quarter 2026 results that exceeded its prior guidance, supported by broad-based customer deployments and more than 100% growth in revenue from customers outside its two largest accounts. Revenue increased 64% year over year to $148.8 million, above the company’

Backblaze (NASDAQ:BLZE) reported third-quarter revenue of $47 million, up 26% from a year earlier, as growth in its B2 Cloud Storage business accelerated and the company continued to build capacity for AI-related customer demand. Chief Executive Officer Gleb Budman said Backblaze is positioning B2

Ichor (NASDAQ:ICHR) reported third-quarter revenue growth and margin expansion as demand for semiconductor equipment systems remained strong, while the company continued to manage supply-chain constraints affecting advanced etch and deposition applications. Revenue for the third quarter was $328.7

Advanced Energy Industries (NASDAQ:AEIS) reported record third-quarter 2026 results that exceeded the high end of its guidance, as demand strengthened across semiconductor, data center computing, industrial and medical markets. Revenue rose 21% sequentially to $696 million, an increase of more than

Cerus (NASDAQ:CERS) reported third-quarter product revenue growth of 10% year over year and reaffirmed its 2026 revenue outlook, while also announcing positive top-line results from its Phase III RedeS study of pathogen-reduced red blood cells. Product revenue totaled $57.7 million for the quarter

Adeia (NASDAQ:ADEA) reported third-quarter 2026 revenue of $80.2 million and said it signed eight license agreements during the period, including four with new customers. The company also lowered its full-year revenue outlook, citing the timing of a small number of large and legally complex media li

Aehr Test Systems (NASDAQ:AEHR) reported record revenue and sharply higher bookings for its fiscal 2027 first quarter, citing expanding demand for wafer-level and package-level burn-in systems used in artificial intelligence, data center and power-semiconductor applications. Revenue for the quarter

C3.ai's revenue has collapsed by more than half since early 2025, while SentinelOne has grown every quarter -- a stark divergence that raises questions about market positioning.

FTG already has a role inside the DHC-515, creating a direct supplier connection to expanded waterbomber production.

Anthropic’s amended S-1 shows revenue still growing at a breakneck pace, but sequential growth fell from 144% in Q2 to about 47% in Q3. Is that an early sign its pricing power is slipping ahead of a possible $1.5 trillion IPO?

The chipmaker has topped its own revenue forecast every quarter for over two years. So why have its shares dropped the next day more often than not?

The AI and data mining specialist delivered another quarter of triple-digit U.S. revenue growth and boosted its full-year guidance.

Get ready for a volatile ride.

Core income of $60.6 million reflects balance sheet optimization and merger synergies.

Last week, the stock had its worst day ever.

The company just released some incredible quarterly results, but its valuation is also fairly high.

Emergent Biosolutions (NYSE:EBS) reported third-quarter revenue within its guidance range and updated its full-year outlook, while continuing a multiyear transformation focused on cost control, debt reduction, medical countermeasures and naloxone access. The company recorded third-quarter revenue o